ZBH logo

Zimmer Biomet Holdings WBAG:ZBH Stock Report

Last Price

€102.85

Market Cap

€20.4b

7D

1.0%

1Y

-6.4%

Updated

22 Dec, 2024

Data

Company Financials +

Zimmer Biomet Holdings, Inc.

WBAG:ZBH Stock Report

Market Cap: €20.4b

My Notes

Capture your thoughts, links and company narrative

Zimmer Biomet Holdings, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zimmer Biomet Holdings
Historical stock prices
Current Share PriceUS$102.85
52 Week HighUS$122.45
52 Week LowUS$92.74
Beta1.02
1 Month Change-2.05%
3 Month Change7.05%
1 Year Change-6.37%
3 Year Change-7.55%
5 Year Changen/a
Change since IPO-23.39%

Recent News & Updates

Recent updates

Shareholder Returns

ZBHAT Medical EquipmentAT Market
7D1.0%-1.4%-1.4%
1Y-6.4%5.4%-1.6%

Return vs Industry: ZBH underperformed the Austrian Medical Equipment industry which returned 5.4% over the past year.

Return vs Market: ZBH underperformed the Austrian Market which returned -1.6% over the past year.

Price Volatility

Is ZBH's price volatile compared to industry and market?
ZBH volatility
ZBH Average Weekly Movement2.8%
Medical Equipment Industry Average Movement6.1%
Market Average Movement3.8%
10% most volatile stocks in AT Market6.2%
10% least volatile stocks in AT Market2.1%

Stable Share Price: ZBH has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: ZBH's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192718,000Ivan Tornoswww.zimmerbiomet.com

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products.

Zimmer Biomet Holdings, Inc. Fundamentals Summary

How do Zimmer Biomet Holdings's earnings and revenue compare to its market cap?
ZBH fundamental statistics
Market cap€20.43b
Earnings (TTM)€1.04b
Revenue (TTM)€7.28b

19.7x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZBH income statement (TTM)
RevenueUS$7.60b
Cost of RevenueUS$2.13b
Gross ProfitUS$5.46b
Other ExpensesUS$4.38b
EarningsUS$1.08b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.44
Gross Margin71.90%
Net Profit Margin14.27%
Debt/Equity Ratio53.6%

How did ZBH perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

18%

Payout Ratio

Does ZBH pay a reliable dividends?

See ZBH dividend history and benchmarks
When do you need to buy ZBH by to receive an upcoming dividend?
Zimmer Biomet Holdings dividend dates
Ex Dividend DateDec 30 2024
Dividend Pay DateJan 31 2025
Days until Ex dividend7 days
Days until Dividend pay date39 days

Does ZBH pay a reliable dividends?

See ZBH dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zimmer Biomet Holdings, Inc. is covered by 63 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Stephan GasteygerAtlantic Equities LLP
Jeffrey JohnsonBaird